IDEX CORP /DE/ IEX revenue by segment, product and geography
In its fiscal year ending 2025-12-31, IDEX CORP /DE/ reported revenue across 3 business segments; the largest, Health And Science Technologies, was $1.49B, 43.1% of the filed sum (+15.2% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Health And Science Technologies$1.49B43.1%+15.2% yoy
- Fluid And Metering Technologies$1.22B35.4%-0.8% yoy
- Fire And Safety Diversified Products$744M21.5%+0.2% yoy
Members sum to the consolidated $3.46B for this period.
- United States$1.76B50.8%+8.6% yoy
- Europe$846M24.4%+6.2% yoy
- Asia$563M16.2%-1.4% yoy
- Other Geographical Areas$165M4.8%+7.2% yoy
- North America Excluding United States$130M3.7%-2.0% yoy
Members sum to the consolidated $3.46B for this period.
- Health And Science Technologies$414M45.0%+13.8% yoy
- Fluid And Metering Technologies$317M34.4%+2.0% yoy
- Fire And Safety Diversified Products$190M20.6%-0.6% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.